Inorganic shaped bodies and methods for their production and use
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/14
A61F-002/00
출원번호
US-0999506
(2001-11-15)
발명자
/ 주소
Sapieszko, Ronald S.
Dychala, David H.
Erbe, Erik M.
출원인 / 주소
Vita Special Purpose Corporation
대리인 / 주소
Woodcock Washburn LLP
인용정보
피인용 횟수 :
64인용 특허 :
37
초록▼
Shaped, preferably porous, inorganic bodies are provided which are prepared from a reactive blend. In accordance with one preferred embodiment, the solution is absorbed into a porous sacrificial substrate such as a cellulose sponge. The solution-saturated substrate is heated and an oxidation-reducti
Shaped, preferably porous, inorganic bodies are provided which are prepared from a reactive blend. In accordance with one preferred embodiment, the solution is absorbed into a porous sacrificial substrate such as a cellulose sponge. The solution-saturated substrate is heated and an oxidation-reduction reaction occurs thereby forming an inorganic solid. A shaped, inorganic body is formed in situ. Optional, but preferred additional thermal treatment of the shaped, inorganic body removes the organic substrate, leaving an inorganic body that faithfully mimics the porosity, shape, and other physical characteristics of the organic substrate. Inorganic substrates may also be used to good effect. Large varieties of shaped bodies can be prepared in accordance with other embodiments of the invention and such shapes find wide use in surgery, laboratory and industrial processes and otherwise. The invention also provides chemically and morphologically uniform powders, including those having uniformly small sizes.
대표청구항▼
Shaped, preferably porous, inorganic bodies are provided which are prepared from a reactive blend. In accordance with one preferred embodiment, the solution is absorbed into a porous sacrificial substrate such as a cellulose sponge. The solution-saturated substrate is heated and an oxidation-reducti
Shaped, preferably porous, inorganic bodies are provided which are prepared from a reactive blend. In accordance with one preferred embodiment, the solution is absorbed into a porous sacrificial substrate such as a cellulose sponge. The solution-saturated substrate is heated and an oxidation-reduction reaction occurs thereby forming an inorganic solid. A shaped, inorganic body is formed in situ. Optional, but preferred additional thermal treatment of the shaped, inorganic body removes the organic substrate, leaving an inorganic body that faithfully mimics the porosity, shape, and other physical characteristics of the organic substrate. Inorganic substrates may also be used to good effect. Large varieties of shaped bodies can be prepared in accordance with other embodiments of the invention and such shapes find wide use in surgery, laboratory and industrial processes and otherwise. The invention also provides chemically and morphologically uniform powders, including those having uniformly small sizes. no acid sequence in SEQ. ID. NO: 11, and said CDR3' comprises the amino acid sequence in SEQ. ID. NO: 12; or said CDR1, CDR2, CDR3, CDR1', CDR2' and CDR3' taken in sequence as a whole comprise an amino acid sequence which is at least 95% identical to SEQ. ID. Nos. 7, 8, 9, 10, 11 and 12 taken in sequence as a whole. 7. A CD25 binding molecule according to claim 6 wherein said CDR1comprises the amino acid sequence in SEQ. ID. NO: 7, said CDR2 comprises the amino acid sequence in SEQ. ID. NO: 8, said CDR3 comprises the amino acid sequence in SEQ. ID. NO: 9, said CDR1' comprises the amino acid sequence in SEQ. ID. 10, said CDR2' comprises the amino acid sequence in SEQ. ID. NO: 11, and said CDR3' comprises the amino acid sequence in SEQ. ID. NO: 12. 8. A CD25 binding molecule according to claim 7 wherein said CDR1 consists of the amino acid sequence in SEQ. ID. NO: 7, said CDR2 consists of the amino acid sequence in SEQ. ID. NO: 8, said CDR3 consists of the amino acid sequence in SEQ. ID. NO: 9, said CDR1' consists of the amino acid sequence in SEQ. ID. NO: 10, said CDR2' consists of the amino acid sequence in SEQ. ID. NO: 11 and said CDR3' consists of the amino acid sequence in SEQ. ID. NO: 12. 9. A CD25 binding molecule according to claim 6 wherein the first domain comprises the amino acid sequence in SEQ. ID. NO: 3 and the second domain comprises the amino acid sequence in SEQ. ID. NO: 6. 10. A CD25 binding molecule according to claim 9 wherein the first domain consists of the amino acid sequence in SEQ. ID. NO: 3 and the second domain consists of the amino acid sequence in SEQ. ID. NO: 6. 11. A single chain CD25 binding molecule which comprises at least one antigen binding site comprising: (a) a first domain comprising in sequence hypervariable regions CDR1, CDR2 and CDR3, said hypervariable regions alternating with framework regions, (b) a second domain comprising in sequence hypervariable regions CDR1', CDR2' and CDR3', said hypervariable regions alternating with framework regions, and (c) a peptide linker which is bound either to the N-terminus of the first domain and the C-terminus of the second domain or to the C-terminus of the first domain and the N-terminus of the second domain, wherein said CDR1 comprises the amino acid sequence in SEQ. ID. NO: 7, said CDR2 comprises the amino acid sequence in SEQ. ID. NO: 8, said CDR3 comprises the amino acid sequence in SEQ. ID. NO: 9, said CDR1' comprises the amino acid sequence in SEQ. ID. 10, said CDR2' comprises the amino acid sequence in SEQ. ID. NO: 11, and said CDR3' comprises the amino acid sequence in SEQ. ID. NO: 12; or said CDR1, CDR2, CDR3, CDR1', CDR2' and CDR3' taken in sequence as a whole comprise an amino acid sequence which is at least 90% identical to SEQ. ID. Nos. 7, 8, 9, 10, 11 and 12 taken in sequence as a whole. 12. A single chain CD25 binding molecule according to claim 11 wherein said CDR1 comprises the amino acid sequence in SEQ. ID. NO: 7, said CDR2 comprises the amino acid sequence in SEQ. ID. NO: 8, said CDR3 comprises the amino acid sequence in SEQ. ID. NO: 9, said CDR1' comprises the amino acid sequence in SEQ. ID. 10, said CDR2' comprises the amino acid sequence in SEQ. ID. NO: 11, and said CDR3' comprises the amino acid sequence in SEQ. ID. NO: 12. 13. A single chain CD25 binding molecule according to claim 11 wherein the first domain comprises the amino acid sequence in SEQ. ID. NO:3 and the second domain comprises the amino acid sequence in SEQ. ID. NO:6. 14. A single chain CD25 binding molecule according to claim 13 wherein the first domain consists of the amino acid sequence in SEQ. ID. NO:3, the second domain consists of the amino acid sequence in SEQ. ID. NO:6, and the peptide linker consists of from 10 to 30 amino acids. 15. A CD25 binding molecule which comprises: (a) an immunoglobulin heavy chain or fragment thereof which comprises (i) a variable domain comprising in sequence hypervariable regions CDR1, CDR2 and CDR3, said hy
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (37)
Erbe Erik M. (Berwyn PA), Bioactive load bearing bone graft compositions.
Brown Walter E. (Rockville MD) Chow Laurence C. (Germantown MD), Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements.
Bauer Gerd (Darmstadt DEX) Kuntz Matthias (Muhltal DEX) Grobelsek Ingrid (Darmstadt DEX) Reyermann Dirk (Darmstadt DEX) Nimtz Gunter (Knigsdorf DEX), Process and apparatus for the preparation of pulverulent metal oxides for ceramic compositions.
Bolt John D. (Landenberg PA) Subramanian Munirpallam A. (New Castle DE), Process for making 90°K. superconductors by impregnating cellulosic article with precursor solution.
Zhen Yong S. (Downers Grove IL) Hrdina Kenneth (Glenview IL), Process for preparing submicron/nanosize ceramic powders from precursors incorporated within a polymeric foam.
Farris Edward T. (4715 Greenville Ave. Dallas TX 75206) Barsa John J. (60 Haven Ave. New York NY 10032) Lagow Richard J. (6204 Shadow Mountain Dr. Austin TX 78731) Capano Paul J. (1730 E. Oltorf Aust, Solid calcium phosphate materials.
Ison Ira C. (Campbell CA) Fulmer Mark T. (San Jose CA) Barr Bryan M. (San Jose CA) Constantz Brent R. (Los Gatos CA), Storage stable calcium phosphate cements.
Imura Akitoshi (Sakai JPX) Saito Toru (Takatsuki JPX) Ikegami Shiro (Ibaragi JPX), Tetracalcium phosphate-based materials and process for their preparation.
Asius, Jerome; Asius, Benedicte, Ceramic-based injectable implants which are used to fill wrinkles, cutaneous depressions and scars, and preparation method thereof.
Beam,Heather Ann; Bradbury,Thomas J.; Chesmel,Kathleen D.; Gaylo,Christopher M.; Litwak,Alfred Anthony; Liu,Qing; Materna,Peter Albert; Monkhouse,Donald; Patterson,Jennifer; Pryor,Timothy J.; Saini,S, Method and apparatus for engineered regenerative biostructures such as hydroxyapatite substrates for bone healing applications.
Fei, Weifeng; Hill, Arnold; Tellam, Mark, Methods for synthesizing bulk, composite and hybrid structures from polymeric ceramic precursors as well as other polymeric substances and compounds.
Rubbert, Ruedger; Berndt, Ernst-Ulrich; Marquard, Jakob Sebastian; Schmidt-Martens, Hauke; Nesbit, Lea Ellermeier, Methods of designing and manufacturing customized dental prosthesis for periodontal or osseointegration and related systems.
Deslauriers, Richard Joseph; Sendijarevic, Aisa, Methods of performing medical procedures that promote bone growth, methods of making compositions that promote bone growth, and apparatus for use in such methods.
Garigapati, Venkat R.; Hess, Brian J.; Kimsey, Cassandra L.; Murphy, Matthew E., Organophosphorous, multivalent metal compounds, and polymer adhesive interpenetrating network compositions and methods.
Bagga, Charanpreet S.; Koblish, Antony; Erbe, Erik M.; Clineff, Theodore D.; Brown, Steven B.; Nagvajara, Gina M., Pliable conformable bone restorative.
O'Mahony, Donal; Garigapati, Venkat R.; Sun Wai, Adrian; Hess, Brian; Murphy, Matthew E., Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same.
O'Mahony, Donal; Garigapati, Venkat R.; Sun Wai, Adrian; Hess, Brian; Murphy, Matthew E., Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same.
Bagga, Charanpreet S.; Clineff, Theodore D.; Erbe, Erik M.; Paris, Michael W.; Nagvajara, Gina M.; Koblish, Antony, Shapeable bone graft substitute and instruments for delivery thereof.
Bagga, Charanpreet S.; Clineff, Theodore D.; Erbe, Erik M.; Paris, Michael W.; Nagvajara, Gina M.; Koblish, Antony, Shapeable bone graft substitute and instruments for delivery thereof.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.